Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues

Lok, 2009, AASLD practice guidelines, Hepatology, 50, 1 Hoofnagle, 2007, Management of hepatitis B: summary of a clinical research workshop, Hepatology, 45, 1056, 10.1002/hep.21627 Bertoletti, 2003, Kinetics of the immune response during HBV and HCV infection, Hepatology, 38, 4, 10.1053/jhep.2003.50310 Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nat Rev Immunol, 5, 215, 10.1038/nri1573 Boni, 2007, Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection, J Virol, 81, 4215, 10.1128/JVI.02844-06 Webster, 2004, Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy, J Virol, 78, 5707, 10.1128/JVI.78.11.5707-5719.2004 Chang, 2007, The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection, Hepatology, 46, 1332, 10.1002/hep.21844 Wherry, 2004, Memory CD8 T-cell differentiation during viral infection, J Virol, 78, 5535, 10.1128/JVI.78.11.5535-5545.2004 Wherry, 2005, Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination, J Virol, 79, 8960, 10.1128/JVI.79.14.8960-8968.2005 Penna, 2012, Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis, J Hepatol, 56, 1239, 10.1016/j.jhep.2011.12.032 Wherry, 2004, Antigen-independent memory CD8 T cells do not develop during chronic viral infection, Proc Natl Acad Sci U S A, 101, 16004, 10.1073/pnas.0407192101 Youngblood, 2011, Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8+ T cells, Immunity, 35, 400, 10.1016/j.immuni.2011.06.015 Boni, 1998, Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B, J Clin Invest, 102, 968, 10.1172/JCI3731 Boni, 2001, Lamivudine treatment can overcome cytotoxic T cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy, Hepatology, 33, 963, 10.1053/jhep.2001.23045 Boni, 2003, Transient restoration of anti-viral therapy in chronic hepatitis, J Hepatol, 39, 595, 10.1016/S0168-8278(03)00292-7 Stoop, 2007, Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B, Virology, 361, 141, 10.1016/j.virol.2006.11.018 Cooksley, 2008, Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity, Antimicrob Agents Chemother, 52, 312, 10.1128/AAC.00467-07 Carey, 2011, Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy, J Virol, 85, 2416, 10.1128/JVI.01449-10 Chen, 2011, Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B, Antiviral Res, 91, 23, 10.1016/j.antiviral.2011.04.008 Jiang, 2011, Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies, Cell Mol Immunol, 8, 75, 10.1038/cmi.2010.37 Zhang, 2010, Decreased ratio of Treg cells to Th17 cells correlates with HBV-DNA suppression in chronic hepatitis B patients undergoing entecavir treatment, Plos One, 5, e13869, 10.1371/journal.pone.0013869 Evans, 2008, Programmed death 1 expression during antiviral treatment of chronic hepatitis B: impact of hepatitis B e-antigen seroconversion, Hepatology, 48, 759, 10.1002/hep.22419 Liang, 2011, Cellular immune responses in patients with hepatitis surface antigen seroclearance induced by antiviral therapy, Virol J, 8, 69, 10.1186/1743-422X-8-69 Jiang, 2010, Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil, Mediators Inflamm, 2010, 143026, 10.1155/2010/143026 Abdel-Hakeem, 2010, Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus, J Virol, 84, 10429, 10.1128/JVI.01094-10 Missale, 2012, Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection, Gut, 61, 1076, 10.1136/gutjnl-2011-300515